top of page
DISPOSITIVO CIERRE OREJUELA: Product
DISPOSITIVO CIERRE OREJUELA: Características
image_3.img.WATCHMAN design leadership_E
  • Available in 5 different sizes (from 21mm to 33mm).

  • Recoverable and repositionable.

image_3.img.WATCHMAN design leadership_E
  • It comes preloaded in the introductory system.

  • Access sheath (14F) compatible with all device sizes.

DISPOSITIVO CIERRE OREJUELA: Productos

WATCHMAN ™ LEFT HEADPHONE APPENDIX CLOSING DEVICE

WATCHMAN ™ is a local solution to reduce the risk of stroke in patients with nonvalvular AF.

  • Designed to prevent embolization of thrombi that may form in the left atrial appendage (LAA).

  • Alternative to oral anticoagulants (OAC).

  • Indicated both for suitable patients and for those with contraindications to treatment with OAC (such as warfarin).

WATCHMAN_HighRes_TransparentBackground.i

Proximal surface

image_0.img.watchman_trans_proximal-face

Minimal surface area oriented to the left atrium to reduce thrombus formation after implantation.

Intra OAI design

image_1.img.watchman_trans_intra-laa-des

Exclusive intra-LAA design to avoid contact with the left atrial wall and prevent complications.

Nitinol structure

image_2.img.watchman_trans_nitinol-frame

It conforms to the unique anatomy of the LAA to reduce the risk of embolization.

Watchman ™ implantation technique

DISPOSITIVO CIERRE OREJUELA: Acerca de

History of clinical leadership

  • The largest source of clinical evidence, with more than 2000 patients studied and two randomized clinical trials.

  • After more than four years of follow-up, the LAA Closure WATCHMAN ™ device continues to offer long-term stroke risk reduction without the need for long-term oral anticoagulant therapy.

  • Proven safety and efficacy, as well as statistically superior, is the alternative to long-term warfarin therapy (primary efficacy).

DISPOSITIVO CIERRE OREJUELA: Acerca de
bottom of page